EUVIMEDEUVIMED entdecken
Crossref

A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement

Da Li, Yidan Dong, Lei Yao, Xiaozhe Chen, Yunfeng Li, Xiaohong Deng, Jianhua Li, Mingzhu Wang, Deyu Fu

Cardiovascular Toxicology · 2026-04 · 26 (4)

DOI: 10.1007/s12012-026-10115-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Toxicology, online erschienen am 13.04.2026. Verfasst von Da Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicin…. Hauptthemen laut MEDLINE: Heart Failure, Adverse Drug Reaction Reporting Systems, Cardiovascular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Shanghai Science and Technology Innovation Action Plan, Shanghai "Rising Stars of Medical Talents" Youth Development Program (Youth Medical Talents-Specialist Program), Shanghai Municipal Health Commission Health Industry Clinical Research Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF), the advanced stage of diverse cardiac conditions, poses a significant public health challenge. This study analyzes adverse event (AE) signals associated with HF within the FDA Adverse Event Reporting System (FAERS) database, offering critical insights to guide rational medication use in clinical settings. Adverse event reports (AERs) associated with HF in the FAERS database, spanning from the first quarter of 2004 to the fourth quarter of 2024, were analyzed. The potential HF risk of drugs was assessed using the disproportionality analysis, with findings juxtaposed against the American Heart Association (AHA) drug list. Drug-induced HF cases showed equivalent distribution between male and female, and high rates of rehospitalization and mortality. Prominent hypoglycemic drugs associated with HF included rosiglitazone, pioglitazone, and saxagliptin. Combination therapies, such as metformin/saxagliptin and metformin/rosiglitazone, also demonstrated elevated risks. In the context of pulmonary hypertension, drugs like macitentan, selexipag, and epoprostenol were particularly notable. Analysis against the AHA drug list confirmed stronger signal strength and frequency among Class A drugs, validating our results. Furthermore, drugs not flagged as positively signaling in the AHA registry, such as amiodarone, aliskiren, and testosterone, merit closer scrutiny due to their potential for adverse reactions. Our analysis of the FAERS database has identified medications associated with potential HF risks, providing valuable evidence to inform clinical decision-making and promote the safe use of medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureAdverse Drug Reaction Reporting SystemsCardiovascular AgentsHumansUnited StatesDatabases, FactualFemaleRisk AssessmentRisk FactorsMaleUnited States Food and Drug AdministrationPharmacovigilanceCardiotoxicityTime FactorsHypoglycemic Agents

Stichwörter der Autor:innen

AHAAdverse drug reactionsFAERSHeart failure

Substanzen

Cardiovascular AgentsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Cardiology, Shanxi Provincial Integrated Traditional Chinese Medicine and Western Medicine Hospital, Taiyuan, China.
  • Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. wangmingzhu@shutcm.edu.cn.
  • Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. fdy65@126.com.

Förderung

  • Shanghai Science and Technology Innovation Action Plan
  • Shanghai "Rising Stars of Medical Talents" Youth Development Program (Youth Medical Talents-Specialist Program)
  • Shanghai Municipal Health Commission Health Industry Clinical Research Special Project
  • Shanghai “Rising Stars of Medical Talents” Youth Development Program

Zitieren

APA

Li, D., Dong, Y., Yao, L., Chen, X., Li, Y., Deng, X., Li, J., Wang, M., & Fu, D. (2026). A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement. Cardiovascular Toxicology, 26(4). https://doi.org/10.1007/s12012-026-10115-w

Vancouver

Li D, Dong Y, Yao L, Chen X, Li Y, Deng X, et al. A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement. Cardiovascular Toxicology. 2026;26(4). doi:10.1007/s12012-026-10115-w

BibTeX
@article{Li2026,
  author = {Li, Da and Dong, Yidan and Yao, Lei and Chen, Xiaozhe and Li, Yunfeng and Deng, Xiaohong and Li, Jianhua and Wang, Mingzhu and Fu, Deyu},
  title = {A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement},
  journal = {Cardiovascular Toxicology},
  year = {2026},
  volume = {26},
  number = {4},
  doi = {10.1007/s12012-026-10115-w}
}
Kostenlos starten →